Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRAMETINIB Cause Electrocardiogram qt prolonged? 43 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Electrocardiogram qt prolonged have been filed in association with TRAMETINIB. This represents 0.7% of all adverse event reports for TRAMETINIB.

43
Reports of Electrocardiogram qt prolonged with TRAMETINIB
0.7%
of all TRAMETINIB reports
7
Deaths
16
Hospitalizations

How Dangerous Is Electrocardiogram qt prolonged From TRAMETINIB?

Of the 43 reports, 7 (16.3%) resulted in death, 16 (37.2%) required hospitalization, and 5 (11.6%) were considered life-threatening.

Is Electrocardiogram qt prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRAMETINIB. However, 43 reports have been filed with the FAERS database.

What Other Side Effects Does TRAMETINIB Cause?

Pyrexia (1,096) Malignant neoplasm progression (807) Product use in unapproved indication (349) Diarrhoea (325) Nausea (301) Rash (290) Vomiting (289) Fatigue (269) Death (240) Chills (227)

What Other Drugs Cause Electrocardiogram qt prolonged?

QUETIAPINE (1,869) OLANZAPINE (1,325) RIBOCICLIB (1,020) AMIODARONE (1,000) HYDROXYCHLOROQUINE (992) CLOZAPINE (958) CITALOPRAM HYDROBROMIDE (917) ESCITALOPRAM OXALATE (899) ONDANSETRON (881) BUPROPION (853)

Which TRAMETINIB Alternatives Have Lower Electrocardiogram qt prolonged Risk?

TRAMETINIB vs TRAMETINIB DIMETHYL SULFOXIDE TRAMETINIB vs TRANDOLAPRIL TRAMETINIB vs TRANDOLAPRIL\VERAPAMIL TRAMETINIB vs TRANEXAMIC ACID TRAMETINIB vs TRANYLCYPROMINE

Related Pages

TRAMETINIB Full Profile All Electrocardiogram qt prolonged Reports All Drugs Causing Electrocardiogram qt prolonged TRAMETINIB Demographics